Global Gene Therapies for Cancer Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Gene Therapies for Cancer Treatment Market Overview

• 1.1 Product Overview and Scope of Gene Therapies for Cancer Treatment
• 1.2 Classification of Gene Therapies for Cancer Treatment by Types
  • 1.2.1 Global Gene Therapies for Cancer Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Somatic Cell Gene Therapy (SCGT)
  • 1.2.4 Germline Gene Therapy (GGT)
• 1.3 Global Gene Therapies for Cancer Treatment Market by Application
  • 1.3.1 Global Gene Therapies for Cancer Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Cancer Research Centers
  • 1.3.3 Diagnostic Laboratories
  • 1.3.4 Cancer Hospitals
  • 1.3.5 Others
• 1.4 Global Gene Therapies for Cancer Treatment Market by Regions
  • 1.4.1 Global Gene Therapies for Cancer Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapies for Cancer Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Gene Therapies for Cancer Treatment (2014-2024)

2 Manufacturers Profiles

• 2.1 Takara Bio
  • 2.1.1 Business Overview
  • 2.1.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Takara Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Tocagen
  • 2.2.1 Business Overview
  • 2.2.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Tocagen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 VBL Therapeutics
  • 2.3.1 Business Overview
  • 2.3.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Cold Genesys
  • 2.4.1 Business Overview
  • 2.4.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Cold Genesys Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Genprex
  • 2.5.1 Business Overview
  • 2.5.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Genprex Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Momotaro-Gene
  • 2.6.1 Business Overview
  • 2.6.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 MultiVir
  • 2.7.1 Business Overview
  • 2.7.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 MultiVir Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 SynerGene Therapeutics
  • 2.8.1 Business Overview
  • 2.8.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Ziopharm Oncology
  • 2.9.1 Business Overview
  • 2.9.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Anchiano Therapeutics
  • 2.10.1 Business Overview
  • 2.10.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Celgene
  • 2.11.1 Business Overview
  • 2.11.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Celgene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Celsion
  • 2.12.1 Business Overview
  • 2.12.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Celsion Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Bluebird Bio
  • 2.13.1 Business Overview
  • 2.13.2 Gene Therapies for Cancer Treatment Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Gene Therapies for Cancer Treatment Market Competition, by Players

• 3.1 Global Gene Therapies for Cancer Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Gene Therapies for Cancer Treatment Players Market Share
  • 3.2.2 Top 10 Gene Therapies for Cancer Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Gene Therapies for Cancer Treatment Market Size by Regions

• 4.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Regions
• 4.2 North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)

5 North America Gene Therapies for Cancer Treatment Revenue by Countries

• 5.1 North America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
• 5.2 USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)

6 Europe Gene Therapies for Cancer Treatment Revenue by Countries

• 6.1 Europe Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries

• 7.1 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
• 7.2 China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)

8 South America Gene Therapies for Cancer Treatment Revenue by Countries

• 8.1 South America Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Gene Therapies for Cancer Treatment by Countries

• 9.1 Middle East and Africa Gene Therapies for Cancer Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2014-2019)

10 Global Gene Therapies for Cancer Treatment Market Segment by Type

• 10.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2019-2024)
• 10.3 Somatic Cell Gene Therapy (SCGT) Revenue Growth Rate (2014-2024)
• 10.4 Germline Gene Therapy (GGT) Revenue Growth Rate (2014-2024)

11 Global Gene Therapies for Cancer Treatment Market Segment by Application

• 11.1 Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Gene Therapies for Cancer Treatment Market Forecast by Application (2019-2024)
• 11.3 Cancer Research Centers Revenue Growth (2014-2019)
• 11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
• 11.5 Cancer Hospitals Revenue Growth (2014-2019)
• 11.6 Others Revenue Growth (2014-2019)

12 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)

• 12.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2019-2024)
• 12.2 Global Gene Therapies for Cancer Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology